660 related articles for article (PubMed ID: 24285341)
1. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.
Hankey GJ
Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341
[TBL] [Abstract][Full Text] [Related]
2. Personalizing oral anticoagulant treatment in patients with atrial fibrillation.
Capranzano P; Miccichè E; D'Urso L; Privitera F; Tamburino C
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):959-73. PubMed ID: 23957907
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
4. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
[TBL] [Abstract][Full Text] [Related]
5. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
7. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
[TBL] [Abstract][Full Text] [Related]
8. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the efficacy and safety of new oral anticoagulant drugs in the secondary stroke prevention in patients with AF: single center experience based on 311 patients.
Lasek-Bal A; Urbanek T; Gierek D
Int Angiol; 2015 Dec; 34(6):552-61. PubMed ID: 25410296
[TBL] [Abstract][Full Text] [Related]
10. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
11. Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician.
Mookadam M; Shamoun FE; Mookadam F
J Am Board Fam Med; 2015; 28(4):510-22. PubMed ID: 26152444
[TBL] [Abstract][Full Text] [Related]
12. Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.
Steinberg BA; Washam JB
Trends Cardiovasc Med; 2017 Nov; 27(8):567-572. PubMed ID: 28750830
[TBL] [Abstract][Full Text] [Related]
13. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
[TBL] [Abstract][Full Text] [Related]
15. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
[TBL] [Abstract][Full Text] [Related]
16. Which oral anticoagulant for which atrial fibrillation patient: recent clinical trials and evidence-based choices.
Cairns JA
Can J Cardiol; 2013 Oct; 29(10):1165-72. PubMed ID: 23932012
[TBL] [Abstract][Full Text] [Related]
17. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086
[TBL] [Abstract][Full Text] [Related]
18. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
Alberts MJ; Eikelboom JW; Hankey GJ
Lancet Neurol; 2012 Dec; 11(12):1066-81. PubMed ID: 23153406
[TBL] [Abstract][Full Text] [Related]
20. Novel oral anticoagulants for stroke prevention in the geriatric population.
Kim D; Barna R; Bridgeman MB; Brunetti L
Am J Cardiovasc Drugs; 2014 Feb; 14(1):15-29. PubMed ID: 24234513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
